Literature DB >> 23716546

Concordant acute myeloblastic leukemia in monozygotic twins with germline and shared somatic mutations in the gene for CCAAT-enhancer-binding protein α with 13 years difference at onset.

Maruša Debeljak, Lidija Kitanovski, Tadej Pajič, Janez Jazbec.   

Abstract

Entities:  

Keywords:  acute myeloblastic leukemia; bone marrow transplantation; germline CEBPA mutations; monozygotic twins

Mesh：

Substances：

Year:  2013        PMID： 23716546      PMCID： PMC3696596          DOI： 10.3324/haematol.2012.082578

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

Review 1.  Origins of chromosome translocations in childhood leukaemia.

Authors:  Mel F Greaves; Joe Wiemels
Journal:  Nat Rev Cancer       Date:  2003-09       Impact factor: 60.716

2.  Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia.

Authors:  G S Sellick; H E Spendlove; D Catovsky; K Pritchard-Jones; R S Houlston
Journal:  Leukemia       Date:  2005-07       Impact factor: 11.528

3.  Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML.

Authors:  M Stelljes; A Corbacioglu; R F Schlenk; K Döhner; M C Frühwald; C Rossig; K Ehlert; G Silling; C Müller-Tidow; H Juergens; H Döhner; W E Berdel; J Kienast; S Koschmieder
Journal:  Leukemia       Date:  2011-04-01       Impact factor: 11.528

4.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.

Authors:  T Pabst; B U Mueller; P Zhang; H S Radomska; S Narravula; S Schnittger; G Behre; W Hiddemann; D G Tenen
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

5.  Possible explanation of the high concoddance for acute leukaemia in monozygotic twins.

Authors:  B D Clarkson; E A Boyse
Journal:  Lancet       Date:  1971-04-03       Impact factor: 79.321

Review 6.  C/EBPα dysregulation in AML and ALL.

Authors:  Ido Paz-Priel; Alan Friedman
Journal:  Crit Rev Oncog       Date:  2011

Review 7.  Leukemia in twins: lessons in natural history.

Authors:  Mel F Greaves; Ana Teresa Maia; Joseph L Wiemels; Anthony M Ford
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

8.  The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication.

Authors:  Aline Renneville; Nicolas Boissel; Nathalie Gachard; Dina Naguib; Christian Bastard; Stéphane de Botton; Olivier Nibourel; Cécile Pautas; Oumedaly Reman; Xavier Thomas; Claude Gardin; Christine Terré; Sylvie Castaigne; Claude Preudhomme; Hervé Dombret
Journal:  Blood       Date:  2009-03-16       Impact factor: 22.113

9.  Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis.

Authors:  T Pabst; M Eyholzer; J Fos; B U Mueller
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640
  9 in total
  7 in total

1.  Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.

Authors:  Daria V Babushok; Monica Bessler; Timothy S Olson
Journal:  Leuk Lymphoma       Date:  2015-12-23

2.  Index case of acute myeloid leukemia in a family harboring a novel CEBPA germ line mutation.

Authors:  Jodi Ram; Gabrielle Flamm; Marlene Balys; Umayal Sivagnanalingam; Paul G Rothberg; Anwar Iqbal; Jason R Myers; Anthony Corbett; John M Ashton; Jason H Mendler
Journal:  Blood Adv       Date:  2017-03-14

Review 3.  Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).

Authors:  Anna L Brown; Christopher N Hahn; Hamish S Scott
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

4.  Identification of novel CEBPA double mutations capable of promoting familial AML via the suppression of myeloid differentiation.

Authors:  Yunjing Zheng; Hui Zhang; Qin Lu; Xinran Chu; Li Gao; Peifang Xiao; Jian Pan; Shaoyan Hu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

5.  [Investigation and clinical analysis of a family with germline CEBPA mutations in acute myeloid leukemia].

Authors:  J P Zhang; D Lin; S C Wang; Y Li; Y M Chen; Y Wang; H Wei; Y C Mi; J X Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-12-14

6.  The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.

Authors:  Ana Rio-Machin; Tom Vulliamy; Nele Hug; Amanda Walne; Kiran Tawana; Shirleny Cardoso; Alicia Ellison; Nikolas Pontikos; Jun Wang; Hemanth Tummala; Ahad Fahad H Al Seraihi; Jenna Alnajar; Findlay Bewicke-Copley; Hannah Armes; Michael Barnett; Adrian Bloor; Csaba Bödör; David Bowen; Pierre Fenaux; Andrew Green; Andrew Hallahan; Henrik Hjorth-Hansen; Upal Hossain; Sally Killick; Sarah Lawson; Mark Layton; Alison M Male; Judith Marsh; Priyanka Mehta; Rogier Mous; Josep F Nomdedéu; Carolyn Owen; Jiri Pavlu; Elspeth M Payne; Rachel E Protheroe; Claude Preudhomme; Nuria Pujol-Moix; Aline Renneville; Nigel Russell; Anand Saggar; Gabriela Sciuccati; David Taussig; Cynthia L Toze; Anne Uyttebroeck; Peter Vandenberghe; Brigitte Schlegelberger; Tim Ripperger; Doris Steinemann; John Wu; Joanne Mason; Paula Page; Susanna Akiki; Kim Reay; Jamie D Cavenagh; Vincent Plagnol; Javier F Caceres; Jude Fitzgibbon; Inderjeet Dokal
Journal:  Nat Commun       Date:  2020-02-25       Impact factor: 14.919

Review 7.  Female reproductive potential after oncological treatment: a rare case report of acute myeloid leukemia in monozygotic twin sisters with literature review.

Authors:  Tanja Burnik Papler; Eda Vrtacnik Bokal; Nina Jančar
Journal:  J Ovarian Res       Date:  2020-01-03       Impact factor: 4.234
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.